Maryland Terbutaline Pharmaceutical Liability Attorney
Terbutaline and Adverse Health Risks
Terbutaline is primarily used in the treatment of asthma, but has also been widely used to delay and manage preterm labor in pregnant women. This use is not approved by the U.S. Food and Drug Administration (FDA), is discouraged in prescribing information, and may result in neurologic damage to the brain of an infant if administered during pregnancy.
Warnings about the dangers of terbutaline have been issued repeatedly to physicians. Studies have also shown that there is an increased risk of autism or conditions that are on the autism spectrum in fraternal twins, particularly in male fraternal twins. If you were prescribed terbutaline to control preterm labor and you have fraternal twins who have been diagnosed with autism or Autism Spectrum Disorder, you may be eligible to obtain monetary compensation for your damages.
Terbutaline was originally intended to prevent and treat wheezing, shortness of breath and chest tightness caused by asthma, bronchitis and emphysema, and was never studied or approved for use in managing preterm labor. Terbutaline became one of the drugs of choice to control preterm labor, an off-label use of this medication. Many women were given terbutaline pumps that delivered regular doses of terbutaline subcutaneously for several weeks.
On November 13, 1997, the FDA issued a warning to physicians and other health care providers that there was no adequate data to establish the safety and effectiveness of terbutaline administered subcutaneously for controlling preterm labor. Many doctors and insurers, as well as the FDA, recommend that terbutaline and similar drugs not be administered by injection for more than 48-72 hours in either the prevention or long-term management of preterm labor, and that pregnant women should not be given oral terbutaline due to the potential for serious internal heart problems and death. The American College of Obstetricians and Gynecologists also discourages the use of terbutaline for preventing premature labor.
Terbutaline and Birth Defects
Despite the FDA’s warnings, many doctors continued to use prolonged doses of terbutaline to control preterm labor. In 2003 and 2004, researchers from the Duke University Medical Center published data showing that in pregnant rats, terbutaline passed through the placenta to enter the brain of infants, resulting in changes to their brain structure. This was followed in 2007 by a study showing that the developmental brain changes that result from terbutaline exposure in rats resemble the brain abnormalities described in people with autism. As of this date, however, studies in humans are limited and so The Law Offices of Peter Angelos, P.C. is only accepting cases involving fraternal twins who have been diagnosed with autism or Autism Spectrum Disorder whose mothers were administered terbutaline after 24 weeks pregnancy for two or more weeks.
Contact Our Firm to Discuss Your Case
If you live in Maryland, were prescribed prolonged doses of terbutaline for the management of preterm labor, and you have fraternal twins who have been diagnosed with autism or Autism Spectrum Disorder, please bring your case to the attention of our experienced and compassionate Maryland personal injury lawyers . Together, we can explore the circumstances surrounding your case and work to obtain compensation for you and your family’s financial, physical and / or emotional damages.
Schedule a free case evaluation today.